Skip to content
YCW22· Other

Engage Bio

Potent, durable, and redosable non-viral genetic medicines

AcquiredChecked 20h ago
Batch
W22
Status, per YC
Acquired
Team size
10
HQ
San Francisco, CA
In W22398 companies, 44% AI
engagebio.comYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Engage Bio

Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.

San Francisco, CA, USA

Engage Bio: questions

Which YC batch was Engage Bio in?

Engage Bio was in Y Combinator's Winter 2022 batch (W22).

Is Engage Bio still active?

Y Combinator lists Engage Bio as acquired.

Where is Engage Bio based?

Engage Bio lists San Francisco, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.